SD

Sakya Duvvuru

North America, California, United States, San Francisco

Description

Sakya Duvvuru - Partner @ Marcho Partners

Investor Profile

Sakya Duvvuru has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Convertible Note rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Convertible Note (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sakya Duvvuru frequently co-invest with?

Natural Capital
North America, California, United States, Palo Alto
Co-Investments: 1
Helios Capital
North America, New York, United States, New York
Co-Investments: 1
Sand Hill Angels
North America, California, United States, Mountain View
Co-Investments: 1
Plum Alley
North America, New York, United States, New York
Co-Investments: 1
ZV
North America, British Columbia, Canada, Vancouver
Co-Investments: 1
Tribe Capital
North America, California, United States, San Francisco
Co-Investments: 1

Which angels does Sakya Duvvuru often collaborate with?

PD
North America, California, United States, Menlo Park
Shared Deals: 1
KA
North America, California, United States, San Francisco
Shared Deals: 1
BG
North America, California, United States, San Francisco
Shared Deals: 1
Shared Deals: 1
SA
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Sakya Duvvuru?

Ashvattha Therapeutics

Redwood City, California, United States

Ashvattha Therapeutics is a biotechnology company that creates products that selectively target and treat human diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Convertible NoteMay 31, 2020
Amount Raised: $22,000,000